Shifting Trends and Informed Decision-Making in the Management of Graves' Disease
- PMID: 32046610
- PMCID: PMC7074894
- DOI: 10.1089/thy.2020.0114
Shifting Trends and Informed Decision-Making in the Management of Graves' Disease
Conflict of interest statement
No competing financial interests exist.
Comment on
-
Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.Thyroid. 2020 Mar;30(3):357-364. doi: 10.1089/thy.2019.0132. Epub 2020 Feb 26. Thyroid. 2020. PMID: 31973681
References
-
- Cramon P, Winther KH, Watt T, Bonnema SJ, Bjorner JB, Ekholm O, Groenvold M, Hegedüs L, Feldt-Rasmussen U, Rasmussen ÅK 2016. Quality-of-life impairments persist six months after treatment of Graves' hyperthyroidism and toxic nodular goiter: a prospective cohort study. Thyroid 26:1010–1018 - PubMed
-
- Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson P, Benjamin EJ, D'Agostino RB. 1994. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249–1252 - PubMed
-
- Chen Q, Yan Y, Zhang L, Cheng K, Liu Y, Zhu W. 2014. Effect of hyperthyroidism on the hypercoagulable state and thromboembolic events in patients with atrial fibrillation. Cardiology 127:176–182 - PubMed
-
- Squizzato A, Gerdes VEA, Brandjes DPM, Buller HR, Stam J. 2005. Thyroid diseases and cerebrovascular disease. Stroke 36:2302–2310 - PubMed
-
- Biondi B. 2012. Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol 167:609–618 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
